| pubmed-article:18662379 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18662379 | lifeskim:mentions | umls-concept:C0024109 | lld:lifeskim |
| pubmed-article:18662379 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:18662379 | lifeskim:mentions | umls-concept:C0178602 | lld:lifeskim |
| pubmed-article:18662379 | lifeskim:mentions | umls-concept:C1947976 | lld:lifeskim |
| pubmed-article:18662379 | lifeskim:mentions | umls-concept:C0729296 | lld:lifeskim |
| pubmed-article:18662379 | pubmed:dateCreated | 2008-8-13 | lld:pubmed |
| pubmed-article:18662379 | pubmed:abstractText | To investigate the influence of inhomogeneity corrections on stereotactic treatment plans for non-small cell lung cancer and determine the dose delivered to the PTV and OARs. | lld:pubmed |
| pubmed-article:18662379 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18662379 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18662379 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18662379 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18662379 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18662379 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18662379 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18662379 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18662379 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18662379 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18662379 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18662379 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18662379 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18662379 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18662379 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18662379 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18662379 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18662379 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18662379 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18662379 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18662379 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18662379 | pubmed:issn | 1748-717X | lld:pubmed |
| pubmed-article:18662379 | pubmed:author | pubmed-author:HurkmansCoen... | lld:pubmed |
| pubmed-article:18662379 | pubmed:author | pubmed-author:SchuringDanny... | lld:pubmed |
| pubmed-article:18662379 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:18662379 | pubmed:volume | 3 | lld:pubmed |
| pubmed-article:18662379 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18662379 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18662379 | pubmed:pagination | 21 | lld:pubmed |
| pubmed-article:18662379 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
| pubmed-article:18662379 | pubmed:meshHeading | pubmed-meshheading:18662379... | lld:pubmed |
| pubmed-article:18662379 | pubmed:meshHeading | pubmed-meshheading:18662379... | lld:pubmed |
| pubmed-article:18662379 | pubmed:meshHeading | pubmed-meshheading:18662379... | lld:pubmed |
| pubmed-article:18662379 | pubmed:meshHeading | pubmed-meshheading:18662379... | lld:pubmed |
| pubmed-article:18662379 | pubmed:meshHeading | pubmed-meshheading:18662379... | lld:pubmed |
| pubmed-article:18662379 | pubmed:meshHeading | pubmed-meshheading:18662379... | lld:pubmed |
| pubmed-article:18662379 | pubmed:meshHeading | pubmed-meshheading:18662379... | lld:pubmed |
| pubmed-article:18662379 | pubmed:meshHeading | pubmed-meshheading:18662379... | lld:pubmed |
| pubmed-article:18662379 | pubmed:meshHeading | pubmed-meshheading:18662379... | lld:pubmed |
| pubmed-article:18662379 | pubmed:meshHeading | pubmed-meshheading:18662379... | lld:pubmed |
| pubmed-article:18662379 | pubmed:meshHeading | pubmed-meshheading:18662379... | lld:pubmed |
| pubmed-article:18662379 | pubmed:meshHeading | pubmed-meshheading:18662379... | lld:pubmed |
| pubmed-article:18662379 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18662379 | pubmed:articleTitle | Developing and evaluating stereotactic lung RT trials: what we should know about the influence of inhomogeneity corrections on dose. | lld:pubmed |
| pubmed-article:18662379 | pubmed:affiliation | Catharina-hospital, Department of radiotherapy, Michelangelolaan 2, PO box 1350, 5602 ZA, Eindhoven, The Netherlands. danny.schuring@cze.nl | lld:pubmed |
| pubmed-article:18662379 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18662379 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18662379 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18662379 | lld:pubmed |
